Expanding the awareness of Alpha-1 antitrypsin deficiency (AATD) to provide a multidisciplinary approach to care

B. Balbi (Veruno (NO), Italy)

Source: Virtual Congress 2020 – Airway diseases
Session: Airway diseases
Session type: Challenging clinical cases
Number: 5130
Disease area: Airway diseases

WebcastSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
B. Balbi (Veruno (NO), Italy). Expanding the awareness of Alpha-1 antitrypsin deficiency (AATD) to provide a multidisciplinary approach to care. Virtual Congress 2020 – Airway diseases

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Research priorities in alpha-1 antitrypsin deficiency (AATD) for healthcare professionals
Source: Virtual Congress 2020 – COPD phenotypes
Year: 2020


Implementation of screening program for alpha-1 antitrypsin deficiency in Spain
Source: Annual Congress 2004 - Emphysema and oxygen therapy
Year: 2004


The patient perspective of alpha-1 antitrypsin deficiency: disease burden and unmet needs
Source: Breathe, 17 (1) 818; 10.1183/20734735.0340-2020
Year: 2021



Patients with Alpha-1 antitrypsin Deficiency due to Null mutations have clinical peculiarities and should require personalized pulmonary management
Source: International Congress 2019 – New molecular signatures in COPD, lung cancer and a1-antitrypsin deficiency
Year: 2019

The Irish national alpha-1 antitrypsin deficiency targeted detection programme
Source: Annual Congress 2013 –Epidemiology of respiratory disease
Year: 2013


Characteristics of zz alpha-1 antitrypsin deficiency patients on the Irish national registry
Source: Annual Congress 2012 - Inflammation in airway diseases: diagnosis and management
Year: 2012

Physician perspectives: monitoring severe AATD and optimising treatment
Source: International Congress 2017 – Clinical challenges in chronic lung diseases
Year: 2017


Diagnosis of alpha 1 antitrypsin deficiency in primary care
Source: International Congress 2015 – Management of COPD and other respiratory diseases in primary care
Year: 2015

Alpha-1 antitrypsin deficiency and pulmonary morbidity in patients with primary immunodeficiency disease: A single center experience
Source: International Congress 2018 – Role of IgE and interleukin (IL)-5 in Th2-cell signatures
Year: 2018

Degree of knowledge among physicians about the diagnosis and treatment of alpha-1 antitrypsin deficiency
Source: International Congress 2015 – COPD: chronic disease and comorbidities
Year: 2015

Assessment of A1-PI dose-exposure and exposure-response relationships in patients with Alpha-1 antitrypsin inhibitor deficiency
Source: International Congress 2015 – New data on established treatments for COPD
Year: 2015


Trends in diagnosis and clinical presentation of alpha-1 antitrypsin deficiency within an Irish population
Source: Annual Congress 2012 - Inflammation in airway diseases: diagnosis and management
Year: 2012

Comparison of exercise training responses in COPD patients with and without Alpha-1 antitrypsin deficiency
Source: International Congress 2018 – Latest advances in pulmonary rehabilitation assessment and content
Year: 2018



Characteristics of COPD patients and alpha-1 antitrypsin deficiency at outpatient respiratory clinics. The EPOCONSUL study.
Source: International Congress 2018 – COPD phenotypes: a1 antitrypsin deficiency and beyond
Year: 2018



Prevalence of alpha-1 antitrypsin deficiency (AATD) in Greater Glasgow and Clyde (GG&C) and current practises
Source: Virtual Congress 2020 – COPD phenotypes
Year: 2020


Screening of alpha-1 antitrypsin deficiency in a blood donors cohort of the North-Italian area
Source: International Congress 2015 – Prevalence of respiratory disease
Year: 2015


Alpha-1 antitrypsin deficiency severity and the risk of COVID-19
Source: Virtual Congress 2021 – Burden and epidemiology of COVID-19
Year: 2021


Homecare setting of longterm augmentation therapy in alpha1 antitrypsin defiency patients leads to clinical stabilization
Source: International Congress 2017 – New frontiers in home care management of chronic lung diseases
Year: 2017



Diagnosing alpha 1-antitrypsin deficiency: how to improve the current algorithm
Source: Eur Respir Rev 2015; 24: 52-57
Year: 2015



Challenges in interpreting trends in testing for a1-antitrypsin deficiency in COPD patients from UK primary care
Source: Eur Respir J, 52 (6) 1801986; 10.1183/13993003.01986-2018
Year: 2018